Shuixiu Peng
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 27, 2026
Anti-BCMA/GPRC5D CAR T cells in patients with relapsed or refractory multiple myeloma who have extraosseous extramedullary disease.
Journal: Blood
Published: February 03, 2026
Development and optimisation strategies for a nomogram-based predictive model of malignancy risk in thyroid nodules.
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: January 30, 2026
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: November 30, 2024
Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 16, 2024
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial.
Journal: The Lancet. Haematology
Published: March 10, 2024
Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 07, 2023
Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia.
Journal: Journal of hematology & oncology
Published: January 19, 2023
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 29, 2021
Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 04, 2021
The role of word recognition score in outcomes assessmentof idiopathic sudden sensorineural hearing loss
Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
Published: February 24, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026